GlassScriptPhysician profile
Cheryl L Suber
NPI 1245451269
$4,102.22
in general payments reported to CMS, 2019-2025
18 companies · $1,681 in 2025
The $1,681 reported for 2025 was more than what 90% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.24 · 2022: $157 · 2023: $232 · 2024: $2,021 · 2025: $1,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,864 · Travel and Lodging: $937 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,864.13 |
| Travel and Lodging | $937.13 |
| Education | $132.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,242.34 | 2024-2025 | Inspire |
| Axsome Therapeutics, INC. | $597.29 | 2024-2025 | Sunosi, Auvelity |
| Jazz Pharmaceuticals INC. | $555.32 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $514.15 | 2024-2025 | Lumryz |
| Otsuka America Pharmaceutical, INC. | $168.67 | 2021-2024 | Rexulti |
| Neurocrine Biosciences, INC. | $149.32 | 2022-2024 | Ingrezza |
| Azurity Pharmaceuticals, INC. | $137.86 | 2024-2025 | Horizant |
| Abbott Laboratories | $125.30 | 2023 | Freestyle Libre 3 |
| Abbvie INC. | $107.13 | 2023 | |
| Vanda Pharmaceuticals INC. | $106.34 | 2024 | Fanapt |
| Harmony Biosciences LLC | $91.55 | 2024-2025 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $84.61 | 2025 | |
| Lilly USA, LLC | $68.47 | 2025 | Zepbound |
| Alkermes, INC. | $43.41 | 2022 | |
| Idorsia Pharmaceuticals US INC | $39.92 | 2024-2025 | Quviviq, Quviviq |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $38.77 | 2022 | |
| 3b Medical, INC. | $16.63 | 2025 | Luna |
| Pharmacyclics LLC, An Abbvie Company | $15.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Suber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.